Bladder Cancer
Overview
Bladder cancer occurs in tissues of the urinary bladder.
Symptoms include blood or blood clots in the urine, frequent urination, lower
back pain on one side of the body and burning during urination. Risk factors
for bladder cancer include smoking, exposure to substances such as rubber,
certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried
meats and fat, old age, sex and color, certain parasitic infections. Treatment
of bladder cancer includes chemotherapy, surgery, biological therapy and
radiation therapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1418394-bladder-cancer-pipeline-review-h1-2017
Bladder Cancer Industry Major Outlook
The Pharmaceutical and
Healthcare latest pipeline guide Bladder Cancer - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for
Bladder Cancer (Oncology), complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
The Bladder Cancer (Oncology) pipeline guide also reviews of
key players involved in therapeutic development for Bladder Cancer and features
dormant and discontinued projects. The guide covers therapeutics under Development
by Companies /Universities /Institutes, the molecules developed by Companies in
Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I,
IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 9, 51, 43, 1, 52 and
14 respectively. Similarly, the Universities portfolio in Phase II, Phase I,
Preclinical and Discovery stages comprises 4, 2, 11 and 2 molecules,
respectively.
Bladder Cancer (Oncology) pipeline guide helps in identifying
and tracking emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter strategies
to gain competitive advantage. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
Bladder Cancer - Competitive Analysis
Key players are making innovative
developments in Bladder Cancer industry. The same will help in improving the market
performance. Heavy investments are made by major players in the R&D sector
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Bladder Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Bladder Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bladder Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bladder Cancer (Oncology)
- The pipeline guide reviews pipeline therapeutics for Bladder Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bladder Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bladder Cancer (Oncology)
.Continued
For Detailed Reading Please visit @
https://www.wiseguyreports.com/reports/1418394-bladder-cancer-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. Wise Guy Reports understand how essential statistical surveying
information is for your organization or association. Therefore, we have
associated with the top publishers and research firms all specialized in
specific domains, ensuring you will receive the most reliable and up to date
research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment